The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy

被引：98

作者：

Zheng, Xiangjin ^{[1
,2
,3
]}

Li, Wan ^{[1
,2
,3
]}

Ren, Liwen ^{[1
,2
,3
]}

Liu, Jinyi ^{[2
,3
]}

Pang, Xiaocong ^{[2
,3
]}

Chen, Xiuping ^{[4
]}

Kang, De ^{[2
,3
]}

Wang, Jinhua ^{[1
,2
,3
]}

Du, Guanhua ^{[1
,2
,3
]}

机构：

[1] State Key Lab Bioact Subst & Funct Nat Med, Beijing, Peoples R China

[2] Chinese Acad Med Sci, Inst Mat Med, Key Lab Drug Target Res & Drug Screen, Beijing 100050, Peoples R China

[3] Peking Union Med Coll, Beijing 100050, Peoples R China

[4] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China

来源：

PHARMACOLOGY & THERAPEUTICS | 2019年 / 195卷

基金：

中国国家自然科学基金;

关键词：

Sphingosine kinase 1; Cancer; Mechanism; Inhibitor; PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA CELLS; FTY720 INDUCES APOPTOSIS; UP-REGULATION; INHIBITOR; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID RHEOSTAT; PANCREATIC-CANCER; MOLECULAR-CLONING; MULTIPLE-MYELOMA;

D O I：

10.1016/j.pharmthera.2018.10.011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Sphingolipid metabolites, such as ceramide, sphingosine and sphingosine-1-phosphate (SIP), play many important roles in cellular activities. Ceramide and sphingosine inhibit cell proliferation and induce cell apoptosis while SIP has the opposite effect. Maintaining a metabolic balance of sphingolipids is essential for growth and development of cells. Sphingosine kinase (SPHK) is an important regulator for keeping this balance. It controls the level of SIP and plays important roles in proliferation, migration, and invasion of cancer cells and tumor angiogenesis. There are two isoenzymes of sphingosine kinase, SPHK1 and SPHK2. SPHK1 is ubiquitously expressed in most cancers where it promotes survival and proliferation, while SPHK2 is restricted to only certain tissues and its functions are not well characterized. SPHK1 is currently considered as a novel target for the treatment of cancers. Targeting SPHK1 would provide new strategies for cancer treatment and improve the prognosis of cancer patients. Here we review and summarize the current research findings on the SPHK1-S1P axis in cancer from many aspects including structure, expression, regulation, mechanism, and potential inhibitors. (C) 2018 Elsevier Inc. All rights reserved.

引用

页码：85 / 99

页数：15

共 141 条

[1] Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth facetor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion [J].

Adada, Mohamad M. ;

Canals, Daniel ;

Jeong, Nara ;

Kelkar, Ashwin D. ;

Hernandez-Corbacho, Maria ;

Pulkoski-Gross, Michael J. ;

Donaldson, Jane C. ;

Hannun, Yusuf A. ;

Obeid, Lina M. .

FASEB JOURNAL, 2015, 29 (11) :4654-4669

[2] Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1α during Hypoxia in Human Cancer Cells [J].

Ader, Isabelle ;

Brizuela, Leyre ;

Bouquerel, Pierre ;

Malavaud, Bernard ;

Cuvillier, Olivier .

CANCER RESEARCH, 2008, 68 (20) :8635-8642

[3] Dual role of sphingosine kinase-1 in promoting the differentiation of dermal fibroblasts and the dissemination of melanoma cells [J].

Albinet, V. ;

Bats, M-L ;

Huwiler, A. ;

Rochaix, P. ;

Chevreau, C. ;

Segui, B. ;

Levade, T. ;

Andrieu-Abadie, N. .

ONCOGENE, 2014, 33 (26) :3364-3373

[4] Therapeutic Potential of Targeting SK1 in Human Cancers [J].

Alshaker, Heba ;

Sauer, Lysann ;

Monteil, Danielle ;

Ottaviani, Silvia ;

Srivats, Shyam ;

Boehler, Torsten ;

Pchejetski, Dmitri .

ROLE OF SPHINGOLIPIDS IN CANCER DEVELOPMENT AND THERAPY, 2013, 117 :143-200

[5] Autocrine and paracrine roles of sphingosine-1-phosphate [J].

Alvarez, Sergio E. ;

Milstien, Sheldon ;

Spiegel, Sarah .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2007, 18 (08) :300-307

[6] Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression [J].

Andrieu, Guillaume ;

Ledoux, Adeline ;

Branka, Sophie ;

Bocquet, Magalie ;

Gilhodes, Julia ;

Walzer, Thierry ;

Kasahara, Kousuke ;

Inagaki, Masaki ;

Sabbadini, Roger A. ;

Cuvillier, Olivier ;

Hatzoglou, Anastassia .

SCIENCE SIGNALING, 2017, 10 (472)

[7] Structure-Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors [J].

Baek, Dong Jae ;

MacRitchie, Neil ;

Anthony, Nahoum G. ;

Mackay, Simon P. ;

Pyne, Susan ;

Pyne, Nigel J. ;

Bittman, Robert .

JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (22) :9310-9327

[8] Synthesis of selective inhibitors of sphingosine kinase 1 [J].

Baek, Dong Jae ;

MacRitchie, Neil ;

Pyne, Nigel J. ;

Pyne, Susan ;

Bittman, Robert .

CHEMICAL COMMUNICATIONS, 2013, 49 (21) :2136-2138

[9] FTY720 Induces AutophagyAssociated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism [J].

Bai, Li-Yuan ;

Chiu, Chang-Fang ;

Chiu, Shih-Jiuan ;

Chu, Po-Chen ;

Weng, Jing-Ru .

SCIENTIFIC REPORTS, 2017, 7

[10] Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents [J].

Bandgar, Babasaheb R. ;

Patil, Sachin A. ;

Korbad, Balaji L. ;

Biradar, Satish C. ;

Nile, Shivraj N. ;

Khobragade, Chandrahasya N. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (07) :3223-3227

← 1 2 3 4 5 6 7 8 9 10 →